Maywufa Company Ltd. (1731.TW)

TWD 21.65

(-0.46%)

Long Term Debt Summary of Maywufa Company Ltd.

  • Maywufa Company Ltd.'s latest annual long term debt in 2023 was 438.97 Million TWD , up 100.83% from previous year.
  • Maywufa Company Ltd.'s latest quarterly long term debt in 2024 Q2 was 539.57 Million TWD , up 11.1% from previous quarter.
  • Maywufa Company Ltd. reported annual long term debt of 218.58 Million TWD in 2022, down -28.7% from previous year.
  • Maywufa Company Ltd. reported annual long term debt of 306.58 Million TWD in 2021, up 2.01% from previous year.
  • Maywufa Company Ltd. reported quarterly long term debt of 486.6 Million TWD for 2024 Q1, up 10.91% from previous quarter.
  • Maywufa Company Ltd. reported quarterly long term debt of 438.97 Million TWD for 2023 FY, up 100.83% from previous quarter.

Annual Long Term Debt Chart of Maywufa Company Ltd. (2023 - 2009)

Historical Annual Long Term Debt of Maywufa Company Ltd. (2023 - 2009)

Year Long Term Debt Long Term Debt Growth
2023 438.97 Million TWD 100.83%
2022 218.58 Million TWD -28.7%
2021 306.58 Million TWD 2.01%
2020 300.54 Million TWD -2.5%
2019 308.24 Million TWD 2.75%
2018 300 Million TWD 50.0%
2017 200 Million TWD 0.0%
2016 200 Million TWD 0.0%
2015 200 Million TWD 0.0%
2014 200 Million TWD 0.0%
2013 - TWD -100.0%
2012 300 Million TWD 0.0%
2011 300 Million TWD 0.0%
2010 300 Million TWD 0.0%
2009 300 Million TWD 0.0%

Peer Long Term Debt Comparison of Maywufa Company Ltd.

Name Long Term Debt Long Term Debt Difference
Grape King Bio Ltd 136.36 Million TWD -221.925%
Standard Chem & Pharm CO., LTD. 222.97 Million TWD -96.875%
ScinoPharm Taiwan, Ltd. 570.23 Million TWD 23.018%
Lotus Pharmaceutical Co., Ltd. 9.51 Billion TWD 95.389%
LIWANLI Innovation Co., Ltd. 361 Thousand TWD -121500.277%
YungShin Global Holding Corporation 241.99 Million TWD -81.398%
PhytoHealth Corporation 17.46 Million TWD -2414.187%
SCI Pharmtech, Inc. 845.52 Million TWD 48.082%
Formosa Laboratories, Inc. 2.03 Billion TWD 78.459%
PharmaEssentia Corporation 954.99 Million TWD 54.034%
Bora Pharmaceuticals Co., LTD. 3.48 Billion TWD 87.411%